Added value of serum hormone measurements in risk prediction models for breast cancer for women not using exogenous hormones: Results from the EPIC cohort
- Husing, Anika
- Fortner, Renee T
- Kuhn, Tilman
- Overvad, Kim
- Tjonneland, Anne
- Olsen, Anja
- Boutron Ruault, Marie Christine
- Severi, Gianluca
- Fournier, Agnes
- Boeing, Heiner
- Trichopoulou, Antonia
- Benetou, Vassiliki
- Orfanos, Philippos
- Masala, Giovanna
- Pala, Valeria
- Tumino, Rosario
- Fasanelli, Francesca
- PANICO, SALVATORE
- Bueno de Mesquita, H. Bas
- Peeters, Petra
- van Gils, Carla H
- Quiros, J. Ramon
- Agudo, Antonio
- Sanchez, Maria Jose
- Chirlaque, Maria Dolores
- Barricarte, Aurelio
- Amiano, Pilar
- Khaw, Kay Tee
- Travis, Ruth C
- Dossus, Laure
- Li, Kuanrong
- Ferrari, Pietro
- Merritt, Melissa A
- Tzoulaki, Ioanna
- Riboli, Elio
- Kaaks, Rudolf
Publication date
January 2017
DOI Publisher
American Association for Cancer Research (AACR)Abstract
Circulating hormone concentrations are associated with breast cancer risk, with well-established associations for postmenopausal women. Biomarkers may represent minimally invasive measures to improve risk prediction models
Add to ORKG